Osteopontin gene expression in the aorta and the heart of propylthiouracil-induced hypothyroid mice

Journal of Biomedical Science

Volumn 12, Issue 6, 2005, Pages 869-880

  Liou, Y M ^a   Chang, L Y ^a   Liaw, J M ^a   Jiang, M J ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apolipoprotein E gene knock out mice; Hypothyroid; Lipid cholesterol metabolism; Osteopontin (OPN); Propylthiouracil (PTU)

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; PROPYLTHIOURACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART; HYPOTHYROIDISM; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; TIME SERIES ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CHOLESTEROL; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEART; HEART RATE; HYPOTHYROIDISM; LIPIDS; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, STATISTICAL; MYOCARDIUM; OSTEOPONTIN; PROPYLTHIOURACIL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SIALOGLYCOPROTEINS; THYROXINE; TIME FACTORS; TRIGLYCERIDES; TRIIODOTHYRONINE;

ANIMALIA;

EID: 30544450732     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9023-0     Document Type: Article

References (50)

1. Butler W.T., The nature and significance of osteopontin. Connect Tissue Res. 23: 123-136, 1989.
2. Denhardt D. and Guo X., Osteopontin: a protein with diverse functions. FASEB J. 7: 1475-1482, 1993.
3. Franzen A. and Heinegard D., Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem. J. 232: 715-724, 1985.
4. Brown L.F., Berse B., Vande Water L., Papadopoulos-Sergiou A., Perruzzi C.A., Manseau E.J., Dvorak H.F. and Senger D.R., Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 3: 1169-1180, 1992.
5. Senger D.R., Perruzzi C.A., Papadopoulos A. and Tenen D.G., Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim. Biophys. Acta 1314: 13-24, 1989.
6. Kohri K., Nomura S., Kitamura Y., Nagata T., Yoshioka K., Iguchi M., Yamate T., Umekawa T., Suzuki Y. and Sinohara H., Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J. Biol. Chem. 268: 15180-15184, 1993.
7. John G.A., Burghardt R.C., Spencer T.E., Newton G.R., Ott T.L. and Bazer F.W., Ovine osteopontin II. Osteopontin and alpha(v)beta(3) integrin expression in the uterus and conceptus during the peri-implantation period. Biol. Reprod. 61: 892-899, 1999.
8. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D. and Berman J.S., Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107: 1055-1061, 2001.
9. Giachelli C.M., Bae N., Almeida M., Denhardt D.T., Alpers C.E. and Schwartz S.M., Osteopontin is elevated during neoinitima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92: 1686-1696, 1993.
10. O'Brien E.R., Garvin M.R., Stewart D.K., Hinohara T., Simpson J.B., Schwartz S.M. and Giachelli C.M., Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14: 1648-1656, 1994.
11. O'Brien K.D., Kuusisto J., Reichenbach D.D., Ferguson M., Giachelli C., Alpers C.E. and Otto C.M., Osteopontin is expressed in human aortic valvular lesions. Circulation 92: 2163-2166, 1995.
12. Murray C.E., Giachelli C.M., Schwartz S.M. and Vracko R., Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145: 1450-1462, 1994.
13. Singh K., Sirokman G., Communal C., Robinson K.G., Conrad C.H., Brooks W.W., Bing O.H. and Colucci W.S., Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 33: 663-670, 1999.
14. Burchfiel C.M., Laws A., Benfante R., Goldberg R.J., Hwang L.J., Chiu D., Rodriguez B.L., Curb J.D. and Sharp D.S., Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92: 1430-1436, 1995.
15. Matsui Y., Rittling S.R., Okamoto H., Inobe M., Jia N., Shimizu T., Akino M., Sugawara T., Morimoto J., Kimura C., Kon S., Denhardt D., Kitabatake A. and Uede T., Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23: 1029-1034, 2003.
16. Myers D.L., Harmon K.J., Lindner V. and Liaw L., Alterations of arterial physiology in osteopontin-null mice. Arterioscler. Thromb. Vasc. Biol. 23: 1021-1028, 2003.
17. Ström Å., Franzén , Wängnerud C., Knutsson A.-K., Heinegård D. and Nilsson A.-H., Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J. Vasc. Res. 41: 314-322, 2004.
18. Duntas L.H., Thyroid disease and lipids. Thyroid 12: 287-293, 2002.
19. Salter A.M., Hayashi R., al-Seeni M., Brown N.F., Bruce J., Sorensen O., Atkinson E.A., Middleton B., Bleackley R.C. and Brindley D.N., Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA: cholesterol acyltransferase activities in rat liver. Biochem. J. 276: 825-832, 1991.
20. Staels B., Van Tol A., Chan L., Will H., Verhoeven G. and Auwerx J., Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 127: 1144-1152, 1990.
21. Thompson G.R., Soutar A.K., Spengel F.A., Jadhav A., Gavigan S.J. and Myant N.B., Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc. Natl. Acad. Sci. USA 78: 2591-2595, 1981.
22. Cappola A.R. and Ladenson P.W., Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88: 2438-2444, 2003.
23. Klein I. and Ojamaa K., Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344: 501-509, 2001.
24. Bakker O., Hudig F., Meijssen S. and Wiersinga W.M., Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem. Biophys. Res. Commun. 249: 517-521, 1998.
25. Diekman M.J., Anghelescu N., Endert E., Bakker O. and Wiersinga W.M., Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J. Clin. Endocrinol. Metab. 85: 1857-1862. 2000.
26. Sundaram V., Hanna A.N., Koneru L., Newman H.A. and Falko J.M., Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J. Clin. Endocrinol. Metab. 82: 3421-3424, 1997.
27. Danzi S. and Klein I., Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12: 467-472, 2002.
28. Johnson G.A., Burghardt R.C., Bazer F.W. and Spencer T.E., Osteopontin: roles in implantation and placentation. Biol. Reprod. 69: 1458-1471, 2003.
29. Agnihotri R., Crawford H.C., Haro H., Matrisian L.M., Havrda M.C. and Liaw L., Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J. Biol. Chem. 276: 28261-28267, 2001.
30. Bautista D.S., Denstedt J., Chambers A.F. and Harris J.F., Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J. Cell. Biochem. 61: 402-409, 1996.
31. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M. and Maeda N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Proc. Natl. Acad. Sci. USA 89: 4471-4475, 1992.
32. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M. and Breslow J.L., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992.
33. Rajamannan N.M., Subramaniam M., Springett M., Sebo T.C., Niekrasz M., McConnell J.P., Singh R.J., Stone N.J., Bonow R.O. and Spelsberg T.C., Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105: 2260-2265, 2002.
34. Remaley A.T., Schumacher U.K., Amouzadeh H.R., Brewer H.B. Jr and Hoeg J.M., Identification of novel differentially expressed hepatic genes in cholesterol-fed rabbits by a non-targeted gene approach. J. Lipid Res. 36: 308-314, 1995.
35. Chiba S., Okamoto H., Kon S., Kimura C., Murakami M., Inobe M., Matsui Y., Sugawara T., Shimizu T., Uede T. and Kitabatake A., Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 16: 111-117, 2002.
36. Giachelli C.M., Schwartz S.M. and Liaw L., Molecular and cellular biology of osteopontin role in cardiovascular disease. Trends Cardiovasc. Med. 5: 88-95, 1995.
37. Isoda K., Kamezawa Y., Ayaori M., Kusuhara M., Tada N. and Ohsuzu F., Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 107: 679-681, 2003.
38. Towler D.A., Bidder M., Latifi T., Coleman T. and Semenkovich C.F., Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273: 30427-30434, 1998.
39. Kawamura H., Yokote K., Asaumi S., Kobayashi K., Fujimoto M., Maezawa Y., Saito Y. and Mori S., High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24: 276-281, 2004.
40. Takemoto M., Yokote K., Nishimura M., Shigematsu T., Hasegawa T., Kon S., Uede T., Matsumoto T., Saito Y. and Mori S., Enhanced expression of osteopontin in human diabetic artery ad analysis of its functional role in accelerated atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20: 624-628, 2000.
41. Takemoto M., Yokote K., Yamazaki M., Ridall A.L., Butler W.T., Matsumoto T., Tamura K., Saito Y. and Mori S., Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 258: 722-726, 1999.
42. Bidder M., Shao J.S., Charlton-Kachigian N., Loewy A.P., Semenkovich C.F. and Towler D.A., Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J. Biol. Chem. 277: 44485-44496, 2002.
43. Liaw L., Lindner V., Schwaetz S.M., Chambers A.F. and Giachelli C.M., Osteopontin and β3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ. Res. 77: 665-672, 1995.
44. Patarca R., Saavedra R.A. and Cantor H., Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit. Rev. Immunol. 13: 225-246, 1993.
45. Miyazaki Y., Setoguchi M., Yoshida S., Higuchi Y., Akizuki S. and Yamamoto S., The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J. Biol. Chem. 265: 14432-14438, 1990.
46. Stawowy P., Blaschke F., Pfautsch P., Goetze S., Lippek F., Wollert-Wulf B., Fleck E. and Graf K., Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur. J. Heart Fail 4: 139-146, 2002.
47. Griendling K.K., Sorescu D., Lassegue B. and Ushio-Fukai M., Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20: 2175-2183, 2000.
48. Fresno M., McVay-Boudreau L., Nabel G. and Cantor H., Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells. J. Exp. Med. 153: 1260-1274, 1981.
49. Senger D.R. and Perruzzi C.A., Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim. Biophys. Acta 1314: 13-24, 1996.
50. Kaartinen M.T., Pirhonen A., Linnala-Kankkunen A. and Maenpaa P.H., Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J. Biol. Chem. 274: 1729-1735, 1999.